Investors

This section of the website provides financial reports, investor presentations, information on key corporate transactions and much more.

We strive to be transparent, relevant and accurate in presenting our financial information, in order to inform our stakeholders of the company’s operations and financial position.

If you have any questions, please don’t hesitate to contact us at investors@c-rad.com
Svensk version här

Sign up to our newsletter to keep up to date with investor news

Five reasons to invest in C-RAD

  • Contributing to improved cancer care and ultimately saving human life
  • Several factors point towards surface tracking becoming standard of care – which will unleash a vast market potential for C-RAD with exponential revenue growth
  • C-RAD has a proven and recognized product
  • C-RAD has comprehensive market access with a direct sales force, distributors, and direct cooperation with OEM-vendors
  • C-RAD has a stable financial platform – profitable growth, debt free and +100 MSEK in cash
Learn more

Press releases

2021-07-29 08:30 Continued profitable growth News English Regulatory MAR VPML Report Interim Q2 IR
2021-07-29 08:30 Fortsatt lönsam tillväxt News Swedish Regulatory MAR VPML Report Interim Q2 IR
2021-07-26 08:30 Reminder: C-RAD Web Presentation Half-Year Report 2021 News Corporate Information Other Corporate Information English IR
2021-07-23 11:29 Former employee appeals verdict from the Stockholm Patent and Market court News Corporate Information Other Corporate Information English Regulatory MAR IR
2021-07-23 11:29 Tidigare anställd överklagar dom från Patent- och marknadsdomstolen News Corporate Information Other Corporate Information Swedish Regulatory MAR IR
2021-07-20 08:30 C-RAD announces that the South Florida Proton Therapy Institute has treated its first patient with Catalyst PT News Corporate Information Other Corporate Information English IR

Shares & stock

Please feel free to contact us regarding investments or other financial questions

If you have any questions, please don’t hesitate to contact us